110 related articles for article (PubMed ID: 7812796)
1. The monoclonal antibody Alz-50, used to reveal cytoskeletal changes in Alzheimer's disease, also reacts with a large subpopulation of somatostatin neurons in the normal human hypothalamus and adjoining areas.
van de Nes JA; Sluiter AA; Pool CW; Kamphorst W; Ravid R; Swaab DF
Brain Res; 1994 Aug; 655(1-2):97-109. PubMed ID: 7812796
[TBL] [Abstract][Full Text] [Related]
2. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
[TBL] [Abstract][Full Text] [Related]
3. Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently.
van de Nes JA; Kamphorst W; Ravid R; Swaab DF
Acta Neuropathol; 1998 Aug; 96(2):129-38. PubMed ID: 9705127
[TBL] [Abstract][Full Text] [Related]
4. The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients.
van de Nes JA; Kamphorst W; Ravid R; Swaab DF
Brain; 1993 Feb; 116 ( Pt 1)():103-15. PubMed ID: 7680932
[TBL] [Abstract][Full Text] [Related]
5. Alz-50 immunoreactivity in the hypothalamus of the normal and Alzheimer human and the rat.
Byne W; Mattiace L; Kress Y; Davies P
J Comp Neurol; 1991 Apr; 306(4):602-12. PubMed ID: 2071697
[TBL] [Abstract][Full Text] [Related]
6. Evidence that transmitter-containing dystrophic neurites precede those containing paired helical filaments within senile plaques in the entorhinal cortex of nondemented elderly and Alzheimer's disease patients.
Benzing WC; Brady DR; Mufson EJ; Armstrong DM
Brain Res; 1993 Aug; 619(1-2):55-68. PubMed ID: 7690677
[TBL] [Abstract][Full Text] [Related]
7. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
van de Nes JA; Konermann S; Nafe R; Swaab DF
Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
[TBL] [Abstract][Full Text] [Related]
8. Alz-50 immunohistochemistry in the normal sheep striatum: a light and electron microscope study.
Nelson PT; Marton L; Saper CB
Brain Res; 1993 Jan; 600(2):285-97. PubMed ID: 8094642
[TBL] [Abstract][Full Text] [Related]
9. Tau and ubiquitin in the human hypothalamus in aging and Alzheimer's disease.
Swaab DF; Grundke-Iqbal I; Iqbal K; Kremer HP; Ravid R; van de Nes JA
Brain Res; 1992 Sep; 590(1-2):239-49. PubMed ID: 1330213
[TBL] [Abstract][Full Text] [Related]
10. The monoclonal antibody, Alz 50, recognizes tau proteins in Alzheimer's disease brain.
Nukina N; Kosik KS; Selkoe DJ
Neurosci Lett; 1988 May; 87(3):240-6. PubMed ID: 3132653
[TBL] [Abstract][Full Text] [Related]
11. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease.
Brady DR; Mufson EJ
J Comp Neurol; 1991 Mar; 305(3):489-507. PubMed ID: 2037717
[TBL] [Abstract][Full Text] [Related]
12. Alz-50 antibody recognizes Alzheimer-related neuronal changes.
Hyman BT; Van Hoesen GW; Wolozin BL; Davies P; Kromer LJ; Damasio AR
Ann Neurol; 1988 Apr; 23(4):371-9. PubMed ID: 3382173
[TBL] [Abstract][Full Text] [Related]
13. Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity.
Salehi A; Van de Nes JA; Hofman MA; Gonatas NK; Swaab DF
Brain Res; 1995 Apr; 678(1-2):28-39. PubMed ID: 7620896
[TBL] [Abstract][Full Text] [Related]
14. Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
Tabaton M; Whitehouse PJ; Perry G; Davies P; Autilio-Gambetti L; Gambetti P
Ann Neurol; 1988 Sep; 24(3):407-13. PubMed ID: 3067653
[TBL] [Abstract][Full Text] [Related]
15. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease.
Salehi A; Gonzalez Martinez V; Swaab DF
Neurobiol Aging; 1998; 19(6):505-10. PubMed ID: 10192208
[TBL] [Abstract][Full Text] [Related]
16. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies.
Love S; Saitoh T; Quijada S; Cole GM; Terry RD
J Neuropathol Exp Neurol; 1988 Jul; 47(4):393-405. PubMed ID: 2838588
[TBL] [Abstract][Full Text] [Related]
17. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
18. Alz-50 immunoreactivity in the thalamic reticular nucleus in Alzheimer's disease.
Tourtellotte WG; Van Hoesen GW; Hyman BT; Tikoo RK; Damasio AR
Brain Res; 1990 May; 515(1-2):227-34. PubMed ID: 2357561
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissue.
de la Monte SM; Spratt RA; Chong J; Ghanbari HA; Wands JR
Am J Pathol; 1992 Dec; 141(6):1459-69. PubMed ID: 1466403
[TBL] [Abstract][Full Text] [Related]
20. Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau.
Goedert M; Spillantini MG; Jakes R
Neurosci Lett; 1991 May; 126(2):149-54. PubMed ID: 1717895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
